Výsledky vyhledávání

The prevalence of celiac disease and the appropriateness of the diagnosis in family medicine setting could be lower than expected

Autor: G M, Giorgetti, I, De Vitis, F, Fabiocchi, A, Chiriatti, G, Nati, R, Cantarini, A, Fiorillo, A, Scarabotti, C, Battimelli, W, Elisei, A, Tursi

Publikováno v: European review for medical and pharmacological sciences. 26(14)

To assess the prevalence of celiac disease (CD) and the appropriateness of this diagnosis in the family medicine setting in Italy.The electronic databases of 16 general practitioners working in Rome (Italy) were analyzed. The prevalence of CD accordi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4da3f834660ceb2be15b08746f695242
https://pubmed.ncbi.nlm.nih.gov/35916816

Zobrazit plný text záznamu

COVID-19 in celiac disease: a multicentric retrospective cohort study

Autor: G, Gasbarrini, T, Dionisi, G R, Corazza, N, Aronico, G, Cammarota, G, Ianiro, I, De Vitis, M, Candelli, F A, Mancarella, S, Simeoni, G, Addolorato, F, Bonvicini

Publikováno v: European review for medical and pharmacological sciences. 25(12)

Celiac disease (CD) is an autoimmune disorder, characterized by increased susceptibility to bacterial and viral infections. Therefore, the CD patients could be exposed to an increased risk of contracting SARS-CoV-2, a virus for which the WHO declared

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3779a9c6ede2b4eda340252afc889fc7
https://pubmed.ncbi.nlm.nih.gov/34227075

Zobrazit plný text záznamu

Increased Levels of NF-κB Inhibitors (IκBα and IκBγ) in the Intestinal Mucosa of Crohn's Disease Patients during Infliximab Treatment

Autor: Lucia Gatta, Gino Doria, Giuseppe Fedeli, P. Balistreri, M. Ciarniello, M. Costanzo, Giovanni Gasbarrini, I. De Vitis, Luigia Pace, Carlo Bartoloni, Claudio Pioli, L. Coppola, A. Tricerri, Luisa Guidi

Publikováno v: Scopus-Elsevier

The treatment with infliximab is employed successfully in Crohn's disease (CD) but predictors of efficacy are lacking. Activation of the transcription factor NF-kB has been demonstrated in CD and its inhibition is one of the mechanisms by which anti-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1660766cea1eb8fa9bffa4f12b7cda21
https://doi.org/10.1177/039463200501800116

Zobrazit plný text záznamu

A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome

Autor: R, Urgesi, C, Casale, R, Pistelli, G L, Rapaccini, I, de Vitis

Publikováno v: European review for medical and pharmacological sciences. 18(9)

Irritable bowel syndrome (IBS) is a chronic gastrointestinal (GI) disorder that affects 15-20% of the Western population.There are currently few therapeutic options available for the treatment of IBS. The aim of this study is to evaluate the efficacy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::22599d239a8029982751f938d390bc2b
https://pubmed.ncbi.nlm.nih.gov/24867512

Zobrazit plný text záznamu

Coeliac Disease in the Elderly

Autor: Gino Roberto Corazza, Giovanni Gasbarrini, Rachele Ciccocioppo, I. De Vitis

Publikováno v: Gerontology. 47:306-310

Background: In the last few decades, we have observed either an increased incidence of coeliac disease (CD) or an increased frequency of its diagnosis. However, only scant information is available about the prevalence and clinical features of CD in t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::812217ee27a44bac0730675c4b021ef1
https://doi.org/10.1159/000052819

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání